Novo Nordisk Could Benefit From Latest Fda Warning | Latest News RSS feed WooCommerce

Novo Nordisk Could Benefit From Latest Fda Warning - Latest News


Novo Nordisk Could Benefit From Latest FDA Warning

The FDA recently issued a warning about the linking of Fournier's gangrene with SGLT2 inhibitors used in the treatment of type-2 diabetes. Novo Nordisk claims that its GLP-1 analogues are better ... read more

U.S. FDA panel backs approval of Novo Nordisk diabetes drug

WASHINGTON, Oct 18 (Reuters) - Novo Nordisk A/S's new diabetes ... found that the benefit of reducing blood sugar overall offset this risk, which the company argues is transient. Analysts expect the d... read more

If medicine works, no need to get new one

Unfortunately, the new stuff can also be the expensive. And sometimes, newer isn't always better. I saw some information about a diabetes drug from Novo Nordisk ... The FDA addressed this problem by o... read more

Looking for another news?


Novo, Sanofi go head to head as FDA clears new diabetes drugs

(Reuters) - Rivals Novo Nordisk and Sanofi have won U.S. approval for new combination drugs to treat diabetes ... so there were lots of patients who could benefit. Achieving Xultophy’s full potential ... read more


Novo Nordisk builds R&D capacity in cardiovascular and liver diseases

Subsequently, the FDA approved the medication for CVD-related indications for patients with type 2 diabetes. Results from investigator-sponsored trials and Novo Nordisk ... new drug targets. “If peopl... read more

US FDA seeks additional data from Novo Nordisk's Tresiba and Ryzodeg NDA

Novo Nordisk, a global healthcare company, has received a Complete Response Letter from the US Food and Drug Administration (FDA ... Warning Letter, dated 12 December 2012, have been resolved. "We are ... read more

FDA panel says obesity drug liraglutide is safe, effective

Novo Nordisk's drug liraglutide is safe and effective enough to warrant approval ... It would be sold under the name Saxenda if approved for obesity by the FDA. According to analysts, it could generat... read more

FDA panel recommends approval of Novo Nordisk diabetes drug

The FDA is not obliged ... to start a patient on two new drugs at once. But certain patients in this group, such as those who were needle-shy, could benefit, they said. Dr. Todd Hobbs, U.S. chief medi... read more

Novo Nordisk takes aim at Eli Lilly with U.S. backing of new diabetes drug

WASHINGTON/COPENHAGEN, Oct 19 (Reuters) - Denmark's Novo Nordisk will take aim at Eli ... that the drug's label will to carry a standard warning, similar to insulins, regarding diabetic retinopathy. T... read more

Novo, Sanofi go head to head as FDA clears new diabetes drugs

(Reuters) - Rivals Novo Nordisk and Sanofi have won U.S. approval for new combination drugs to treat diabetes ... so there were lots of patients who could benefit. Achieving Xultophy's full potential ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us